Published in Cancer Res on September 15, 1991
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol (1993) 2.84
Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol (2008) 1.58
Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO J (1992) 1.43
Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. J Virol (1996) 1.35
Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J Clin Invest (1996) 1.33
Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res (2011) 1.33
Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest (1994) 1.19
Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. Neoplasia (2002) 1.06
Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev (1992) 1.04
HBx-DNA probe preparation and its application in study of hepatocarcinogenesis. World J Gastroenterol (1998) 1.03
Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein. Cancer Res (2012) 0.96
Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene (2011) 0.96
Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. World J Gastroenterol (2014) 0.91
Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease. Cancer Lett (2009) 0.86
Significant correlation between expression level of HSP gp96 and progression of hepatitis B virus induced diseases. World J Gastroenterol (2004) 0.82
mTOR in viral hepatitis and hepatocellular carcinoma: function and treatment. Biomed Res Int (2014) 0.82
Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk. Oncotarget (2015) 0.81
Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis. Dig Dis Sci (2001) 0.79
Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis. Neoplasia (2003) 0.79
X region mutations of hepatitis B virus related to clinical severity. World J Gastroenterol (2016) 0.77
A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med (1967) 7.00
Genetic analysis of the human malaria parasite Plasmodium falciparum. Science (1987) 6.48
Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis (1980) 4.28
Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med (1968) 4.28
Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15
Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A (1994) 3.76
An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. N Engl J Med (1969) 3.54
Virulence of avian influenza A viruses for squirrel monkeys. Infect Immun (1982) 3.22
Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol (1995) 2.96
Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A (1984) 2.87
Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science (1979) 2.78
Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers. J Clin Microbiol (1992) 2.50
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol (1975) 2.39
Experimental lead paint poisoning in nonhuman primates. I. Clinical signs and course. J Med Primatol (1976) 2.37
Australia antigen and hepatitis. N Engl J Med (1970) 2.35
The B allele of the NS gene of avian influenza viruses, but not the A allele, attenuates a human influenza A virus for squirrel monkeys. Virology (1989) 2.32
Is chronic hepatitis B being undertreated in the United States? J Viral Hepat (2010) 2.24
Structural relationships between the surface antigens of ground squirrel hepatitis virus and human hepatitis B virus. J Virol (1980) 2.20
Australia antigen and acute viral hepatitis. Ann Intern Med (1969) 2.20
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
Simian immunodeficiency viruses from African green monkeys display unusual genetic diversity. J Virol (1990) 2.09
Evaluation of avian-human reassortant influenza A/Washington/897/80 x A/Pintail/119/79 virus in monkeys and adult volunteers. J Clin Microbiol (1986) 2.06
Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome. JAMA (1968) 1.94
Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene (1993) 1.91
Reassortant virus derived from avian and human influenza A viruses is attenuated and immunogenic in monkeys. Science (1982) 1.86
Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans. Proc Natl Acad Sci U S A (1969) 1.84
Australia antigen and hepatitis. JAMA (1969) 1.81
Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet (1995) 1.80
Isolation of measles virus from brain cell cultures of two patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med (1969) 1.77
Avian-human reassortant influenza A viruses derived by mating avian and human influenza A viruses. J Infect Dis (1984) 1.77
Experimental respiratory syncytial virus infection of four species of primates. J Med Virol (1977) 1.74
Australia antigen as a hepatitis virus. Variation in host response. Am J Med (1970) 1.69
Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologic with virologic observations. Hepatology (1981) 1.67
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma. Lancet (1975) 1.62
Antigenic and structural relationships of the surface antigens of hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis virus. J Virol (1981) 1.61
Antigen and infectivity of HBsAg carriers. Lancet (1976) 1.61
Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science (1978) 1.60
Underestimation of chronic hepatitis B virus infection in the United States of America. J Viral Hepat (2008) 1.58
Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen. J Infect Dis (1972) 1.57
Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis (1975) 1.55
Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J (1990) 1.54
Sex distribution of Australia antigen. Arch Intern Med (1972) 1.52
Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys. Virus Res (1992) 1.51
Evaluation of three strains of influenza A virus in humans and in owl, cebus, and squirrel monkeys. Infect Immun (1980) 1.51
Human-to-human transmission of rabies virus by corneal transplant. N Engl J Med (1979) 1.50
The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. J Neurosurg (1990) 1.48
The nature of polypeptides larger in size than the major surface antigen components of hepatitis b and like viruses in ground squirrels, woodchucks, and ducks. Virology (1983) 1.46
Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells. J Med Primatol (1994) 1.45
A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperature-dependent host range phenotype. Virus Res (1990) 1.42
Naturally occurring infection of Pekin duck embryos by duck hepatitis B virus. Proc Natl Acad Sci U S A (1983) 1.42
Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness. J Med Virol (1978) 1.42
Viral hepatitis, type B, in experimental animals. Am J Med Sci (1976) 1.41
Cholecystokinin and gastrin levels are not elevated in human pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2001) 1.39
Spontaneous substitutions in the vicinity of the V3 analog affect cell tropism and pathogenicity of simian immunodeficiency virus. J Virol (1994) 1.39
Induction of diarrhea in colostrum-deprived newborn rhesus monkeys with the human reovirus-like agent of infantile gastroenteritis. Arch Virol (1976) 1.38
Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge. J Infect Dis (1988) 1.38
Hepatitis B virus and the prevention of primary hepatocellular carcinoma. N Engl J Med (1981) 1.36
Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. Proc Natl Acad Sci U S A (1992) 1.35
Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infect Immun (1983) 1.35
Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci U S A (1989) 1.34
Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates. Infect Immun (1984) 1.34
Major polypeptide of duck hepatitis B surface antigen particles. J Virol (1983) 1.32
Australia antigen-antibody complexes. Nature (1970) 1.32
Duck hepatitis B virus and liver diseases. Gastroenterology (1983) 1.32
Comparison by studies in squirrel monkeys, chimpanzees, and adult humans of avian-human influenza A virus reassortants derived from different avian influenza virus donors. J Clin Microbiol (1986) 1.32
Experimental respiratory syncytial virus pneumonia in cebus monkeys. J Med Virol (1978) 1.30
Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology (1994) 1.29
Natural and experimental infection of woodchucks with woodchuck hepatitis virus, as measured by new, specific assays for woodchuck surface antigen and antibody. J Clin Microbiol (1982) 1.26
Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees. J Clin Microbiol (1991) 1.24
Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun (1977) 1.22
Experimental transmission of the delta agent to chimpanzees. Prog Clin Biol Res (1983) 1.21
Evaluation of the A/Seal/Mass/1/80 virus in squirrel monkeys. Infect Immun (1983) 1.20
Specificities of human antibodies to Australia antigen. Proc Soc Exp Biol Med (1970) 1.20
Infectivity and antigenicity of live avian-human influenza A reassortant virus: comparison of intranasal and aerosol routes in squirrel monkeys. J Infect Dis (1986) 1.19
HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology (1991) 1.19
Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants. Infect Immun (1979) 1.18
A newly identified hepatitis B type virus in tree squirrels. Proc Natl Acad Sci U S A (1986) 1.18
Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene (2006) 1.15
Neutrophil function in children who are carriers of hepatitis-B surface antigen. Lancet (1977) 1.14
Mature liver stages of cloned Plasmodium falciparum share epitopes with proteins from sporozoites and asexual blood stages. Parasite Immunol (1988) 1.14
An attempt to produce chronic nitrite toxicosis in swine. J Am Vet Med Assoc (1967) 1.14
Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine. J Infect Dis (1994) 1.13
Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa. Lancet (1976) 1.13
Australia antigen: detection and transmission in shellfish. Science (1974) 1.13
Persistence of hepatitis B surface antigen in the bedbug Cimex hemipterus (Fabr.). J Infect Dis (1979) 1.13
Sequence of events in natural infection of Pekin duck embryos with duck hepatitis B virus. J Virol (1985) 1.12
Primary hepatocellular carcinoma--etiology, pathogenesis, and prevention. Hum Pathol (1981) 1.12
Epizootiology, transmission and approach to prevention of fatal simian haemorrhagic fever in rhesus monkeys. Nature (1977) 1.12
Microbiological, serological, and histopathological features of experimental Chlamydia trachomatis urethritis in chimpanzees. Br J Vener Dis (1981) 1.11
Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1. Genes Chromosomes Cancer (2001) 1.10